Page last updated: 2024-10-18

imidazole and Graves Disease

imidazole has been researched along with Graves Disease in 2 studies

imidazole: RN given refers to parent cpd
1H-imidazole : An imidazole tautomer which has the migrating hydrogen at position 1.

Graves Disease: A common form of hyperthyroidism with a diffuse hyperplastic GOITER. It is an autoimmune disorder that produces antibodies against the THYROID STIMULATING HORMONE RECEPTOR. These autoantibodies activate the TSH receptor, thereby stimulating the THYROID GLAND and hypersecretion of THYROID HORMONES. These autoantibodies can also affect the eyes (GRAVES OPHTHALMOPATHY) and the skin (Graves dermopathy).

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
BRICAIRE, H1
JOLY, J1
MATHIEUDEFOSSEY, B1
COURJARET, J1
BAILLET, J1
Cornelis, S1
Uttenweiler-Joseph, S1
Panneels, V1
Vassart, G1
Costagliola, S1

Other Studies

2 other studies available for imidazole and Graves Disease

ArticleYear
[EXPLORATION OF THE HYPOPHYSO-THYROID COUPLE BY THE USE OF AN IMIDAZOLE DERIVATIVE. APROPOS OF 25 PERSONAL CASES].
    La Presse medicale, 1964, Oct-17, Volume: 72

    Topics: Antithyroid Agents; Goiter; Graves Disease; Hyperthyroidism; Hypopituitarism; Imidazoles; Metyrapone

1964
Purification and characterization of a soluble bioactive amino-terminal extracellular domain of the human thyrotropin receptor.
    Biochemistry, 2001, Aug-21, Volume: 40, Issue:33

    Topics: Amino Acid Sequence; Animals; Antibodies; Antibodies, Monoclonal; Binding Sites; CHO Cells; Chromato

2001